Holen Sie sich die Stockscreener-App
81.86
0.45%
0.37
Vorhandelsmarkt:
81.01
-0.85
-1.04%
Schlusskurs vom Vortag:
$81.49
Offen:
$81.76
24-Stunden-Volumen:
960.44K
Relative Volume:
0.92
Marktkapitalisierung:
$5.56B
Einnahmen:
$1.50B
Nettoeinkommen (Verlust:
$427.61M
KGV:
13.62
EPS:
6.01
Netto-Cashflow:
$423.98M
1W Leistung:
+1.30%
1M Leistung:
+8.34%
6M Leistung:
-8.50%
1J Leistung:
+1.96%
1-Tages-Spanne:
$80.35
$82.50
1-Wochen-Bereich:
$78.61
$82.50
52-Wochen-Spanne:
$73.11
$126.89
Lantheus Holdings Inc Stock (LNTH) Company Profile
Firmenname
Lantheus Holdings Inc
Sektor
Telefon
978 671-8001
Adresse
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Vergleichen Sie LNTH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
81.86 | 5.56B | 1.50B | 427.61M | 423.98M | 6.01 |
|
RGC
Regencell Bioscience Holdings Ltd
|
17.04 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
155.95 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.37 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.46 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.76 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-18 | Eingeleitet | Goldman | Buy |
| 2024-09-03 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-07-10 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-12-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Eingeleitet | TD Cowen | Outperform |
| 2023-09-29 | Eingeleitet | William Blair | Outperform |
| 2023-03-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-11-30 | Eingeleitet | SVB Leerink | Outperform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-05-09 | Eingeleitet | B. Riley Securities | Buy |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2021-02-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-29 | Fortgesetzt | Jefferies | Buy |
| 2019-08-16 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-09-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2016-02-24 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-12-11 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Eingeleitet | Credit Suisse | Outperform |
| 2015-07-20 | Eingeleitet | Jefferies | Buy |
| 2015-07-20 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-07-20 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-20 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Lantheus Holdings Inc Aktie (LNTH) Neueste Nachrichten
Alzheimer’s Association Partners with Lantheus for 30th Annual Charity Golf Tournament - The Bedford Citizen
Lantheus at 2025 Truist Securities MedTech Conference: Strategic Growth Path - Investing.com Nigeria
Lantheus at 2025 Truist Securities MedTech Conference: Strategic Growth Path By Investing.com - Investing.com South Africa
(LNTH) Technical Data - news.stocktradersdaily.com
The total return for Lantheus Holdings (NASDAQ:LNTH) investors has risen faster than earnings growth over the last five years - simplywall.st
Lantheus Announces Presentations to be featured at the 2025 Soci - GuruFocus
Insider Sell: Julie Mchugh Sells Shares of Lantheus Holdings Inc (LNTH) - GuruFocus
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting - The Manila Times
Lantheus Holdings, Inc. to Present New Data on Oncology Radiodiagnostics at 2025 SNMMI Annual Meeting - Nasdaq
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and ... - Eagle-Tribune
Lantheus Unveils Breakthrough Cancer Diagnostic Results at SNMMI 2025: Multiple Studies Show Promise - Stock Titan
Lantheus at Goldman Sachs Conference: Strategic Expansion in Healthcare By Investing.com - Investing.com South Africa
Lantheus at Goldman Sachs Conference: Strategic Expansion in Healthcare - Investing.com
Transcript : Lantheus Holdings, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 02 - MarketScreener
Lantheus to Present at the 2025 Truist Securities MedTech Conference - The Manila Times
Lantheus CEO Reveals Growth Strategy: Key Insights Coming at Truist MedTech Conference - Stock Titan
Declining Stock and Solid Fundamentals: Is The Market Wrong About Lantheus Holdings, Inc. (NASDAQ:LNTH)? - Yahoo Finance
Investor Network: Lantheus Holdings Inc. to Host Earnings Call - ACCESS Newswire
Investor Network: Lantheus Holdings Inc to Host Earnings Call - ACCESS Newswire
Lantheus to Present at the Goldman Sachs 46th Annual Global Heal - GuruFocus
Lantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 | LNTH Stock News - GuruFocus
Lantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 - The Manila Times
Lantheus CEO to Share Radiopharmaceutical Innovation Strategy at Goldman Sachs Healthcare Conference - Stock Titan
How to Take Advantage of moves in (LNTH) - news.stocktradersdaily.com
PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer - Quantisnow
Lantheus Holdings Inc (LNTH) Shares Up 3.1% on May 27 - GuruFocus
Learn to Evaluate (LNTH) using the Charts - news.stocktradersdaily.com
Lantheus Holdings stock hits 52-week low at $74.92 By Investing.com - Investing.com India
Lantheus Holdings’ SWOT analysis: diagnostic imaging leader faces market shifts - Investing.com India
Lantheus Holdings stock hits 52-week low at $74.92 - Investing.com
Lantheus Holdings, Inc.'s (NASDAQ:LNTH) 25% Cheaper Price Remains In Tune With Earnings - simplywall.st
Lantheus Holdings, Inc. (NASDAQ:LNTH) Receives $132.67 Average PT from Brokerages - Defense World
Cetera Investment Advisers Grows Holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Lantheus Holdings Inc (LNTH) Stock Price Down 2.68% on May 19 - GuruFocus
Lantheus Holdings, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsLNTH - ACCESS Newswire
Lantheus Holdings: Poor Results Caused By Temporary ProblemsA Buy - Seeking Alpha
Radiopharmaceuticals Market Products and Applications Report 2025 | SPECT Radiopharmaceuticals Lead Diagnostic Market with 67% Share - GlobeNewswire Inc.
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore - MarketBeat
Lantheus Holdings (NasdaqGM:LNTH) Adjusts 2025 Earnings Guidance - Yahoo Finance
Shareholders that lost money on Lantheus Holdings, Inc. (LNTH) should contact Levi & Korsinsky about Securities Fraud InvestigationLNTH - ACCESS Newswire
Long Term Trading Analysis for (LNTH) - news.stocktradersdaily.com
Lantheus Holdings, Inc. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsLNTH - ACCESS Newswire
Lantheus projects $1.55B-$1.585B revenue for 2025 amid acquisitions and market growth - MSN
Lantheus Holdings stock drops on lowered full year outlook - MSN
LNTH Q1 Earnings Call: Lantheus Lowers Outlook Amid Product Shifts and Divestitures - Yahoo Finance
Shareholder Rights Advocates at Levi & Korsinsky Investigate Lantheus Holdings, Inc. (LNTH) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Lantheus price target lowered to $120 from $134 at JonesResearch - Yahoo Finance
Lantheus Holdings, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - Yahoo Finance
Truist cuts Lantheus stock price target to $117, maintains Buy By Investing.com - Investing.com South Africa
Lantheus announces pivotal trial win for Alzheimer’s imaging agent - MSN
LNTH: Sale of SPECT Tilts Growth to Novel Radiopharmaceuticals - Research Tree
Finanzdaten der Lantheus Holdings Inc-Aktie (LNTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):